Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYes, you can stop weight loss injections at any time. There is no physical dependency and no clinical requirement to continue indefinitely. What matters is understanding what is likely to happen to your appetite, weight and metabolic patterns once you do — because the evidence is clear that these medicines do not produce permanent changes on their own, and stopping without a plan is the part most people wish they had thought through earlier. These are prescription-only medicines, and any decision about stopping is best made with the prescriber who knows your full picture.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture this: you've been on treatment for several months, you've lost meaningful weight, but for whatever reason, stopping feels like the right call right now. Maybe the cost has become a strain, or you're heading somewhere for a fortnight without refrigeration access, or you simply want to see how you manage independently. The question you're actually asking is not whether stopping is allowed (it is) but what your body is likely to do next.
The most important thing to understand is that tirzepatide and semaglutide (the medicines in Mounjaro and Wegovy) work by activating gut-hormone receptors that regulate appetite and slow gastric emptying. While the medicine is active, hunger signals are quieter than usual. Once you stop, those signals gradually return to their pre-treatment level. For most people this happens over a matter of weeks rather than days (the medicines have relatively long half-lives) but the direction of travel is predictable: appetite comes back, and without a plan to manage it, calorie intake tends to rise.
Clinical trial evidence supports this. The STEP 1 extension, which tracked participants after they stopped semaglutide, found that a substantial proportion of weight lost during treatment was regained within a year of stopping. The NHS medicines page for semaglutide is clear that treatment is meant to work alongside diet and lifestyle changes, not instead of them, and that context becomes especially important when you stop. That is not a reason to keep taking a medicine that no longer suits you; it is a reason to stop with a plan rather than simply skipping your next dose.
A common worry is whether stopping suddenly causes withdrawal symptoms. It does not. Unlike some medicines that require gradual tapering to avoid rebound effects, GLP-1 medicines do not produce physical dependency. The side effects most people experience, typically gastrointestinal symptoms such as nausea or loose stools, occur during dose increases and usually settle as the body adjusts. They do not get worse when you stop; they resolve.
If you are mid-titration when you decide to stop, the pattern is straightforward. The medicine clears your system, appetite returns, and any residual nausea from the most recent dose fades. Some people do notice a brief period of heightened hunger in the first couple of weeks, which is the pharmacological effect unwinding rather than a clinical event, but this is not a medical emergency.
The practical consideration most worth flagging: if you stop and then want to restart later, a prescriber will typically start you again from a lower dose rather than from where you left off, particularly if there has been a gap of several weeks or more. Restarting at a high dose after a break increases the chance of GI side effects. This is worth factoring in if your reason for stopping is temporary, such as upcoming surgery or a holiday where cold storage isn't practical. Whether timing your stop matters is a question worth raising before your next dose, not after.
The evidence on weight regain after stopping is consistent enough to be honest about. Detailed information on what happens when you stop is worth reading alongside this page, but the short version is that regain is common, partial regain is more typical than full regain, and individuals who have built genuine habit changes during treatment tend to regain less. That is not a guarantee; it is a pattern that the research supports.
The factors that seem to matter most are protein intake (which helps preserve muscle mass and supports satiety), consistent physical activity, and whether you have a clear structure around meals rather than eating reactively. These are not new pieces of advice, but they carry more weight in the period after stopping than at almost any other time, because appetite is actively recovering and old patterns can reassert themselves quickly.
Understanding the specific effects on the body after stopping can help you prepare realistically. If cost is a driver, it is worth knowing that the cost of weight loss injections varies by dose and provider, and some people find a lower maintenance dose more affordable than their titration dose once they have reached their target weight. If you are weighing up your options, our guide to the top weight loss injections currently available covers how the main treatments compare, which can be useful context when thinking about whether to pause, switch or continue. Our treatment page has current pricing if that comparison is useful.
If you are considering stopping because of side effects rather than a planned decision, that is exactly the kind of conversation a prescriber should be involved in. Sometimes a slower titration, a brief pause or a switch to a different medicine resolves the issue without losing the clinical benefit you have built up. At our pharmacy, aftercare support is available seven days a week precisely for this kind of question, you do not need to wait for a scheduled review. Our clinical team reviews each case individually, so the answer you get is based on your situation, not a general script.
Stopping a prescription medicine is your decision. Full stop. No one can or should tell you that you are not allowed. What a prescriber can do is give you a clearer picture of your individual risk of regain, help you time a stop if there is a reason to do so, and discuss whether a planned tapering approach makes sense for your situation, though there is no clinical requirement to taper these medicines in the way there is for, say, steroids.
If you started treatment through an online service and are unsure who to contact, that is a gap worth addressing before you stop rather than after. Anyone accessing weight loss injections through a regulated pharmacy should have a clear route to clinical support. At nume, prescribers are reachable seven days a week and a question about stopping is as legitimate as any other aftercare query. You can reach us via our contact page any day of the week.
If you are at the earlier stage of exploring treatment options and want to understand what a full treatment pathway looks like before committing, our breakdown of the top 3 weight loss injections is a good starting point for comparing what each option involves. There are no obligations and no surprises, just a clinical conversation about whether this is right for you.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.